Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway

Antoine, 2011, Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium, Climacteric, 14, 464, 10.3109/13697137.2011.561385 Attele, 1999, Ginseng pharmacology: multiple constituents and multiple actions, Biochem. Pharmacol., 58, 1685, 10.1016/S0006-2952(99)00212-9 Bledsoe, 2002, Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition, Cell, 110, 93, 10.1016/S0092-8674(02)00817-6 Boonyaratanakornkit, 2008, The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression, Steroids, 73, 922, 10.1016/j.steroids.2008.01.010 Bourque, 2009, Neuroprotective actions of sex steroids in Parkinson’s disease, Front. Neuroendocrinol., 30, 142, 10.1016/j.yfrne.2009.04.014 Brzozowski, 1997, Molecular basis of agonism and antagonism in the oestrogen receptor, Nature, 389, 753, 10.1038/39645 Castegna, 2003, Proteomic identification of nitrated proteins in Alzheimer’s disease brain, J. Neurochem., 85, 1394, 10.1046/j.1471-4159.2003.01786.x Chan, 2002, Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng, J. Clin. Endocrinol. Metab., 87, 3691, 10.1210/jcem.87.8.8717 Cristina de Assis, 2002, Expression of inducible nitric oxide synthase in human umbilical vein endothelial cells during primary culture, Nitric Oxide, 7, 254, 10.1016/S1089-8603(02)00123-4 Das, 2009, ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice, Am. J. Physiol. Heart Circ. Physiol., 296, H1236, 10.1152/ajpheart.00100.2009 Du, 2011, Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects, J. Immunol., 10.4049/jimmunol.1002579 Du, 2009, Dynamic regulation of mitochondrial function by glucocorticoids, Proc. Natl. Acad. Sci. U.S.A., 106, 3543, 10.1073/pnas.0812671106 Dusek, 2006, The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes, J. Biol. Chem., 281, 3614, 10.1074/jbc.M508258200 German, 2006, Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/MAPK pathway, J. Neurochem., 98, 1507, 10.1111/j.1471-4159.2006.04061.x Green, 2000, Estradiol attenuation of beta-amyloid-induced toxicity: a comparison o, J. Neurocytol., 29, 419, 10.1023/A:1007173509470 Heck, 1997, I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor, EMBO J., 16, 4698, 10.1093/emboj/16.15.4698 Hensley, 1994, A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 91, 3270, 10.1073/pnas.91.8.3270 Hou, 2009, Ultrasound stimulates NF-kappaB activation and iNOS expression via the Ras/Raf/MEK/ERK signaling pathway in cultured preosteoblasts, J. Cell Physiol., 220, 196, 10.1002/jcp.21751 Janssen-Heininger, 1999, Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants, Am. J. Respir. Cell Mol. Biol., 20, 942, 10.1165/ajrcmb.20.5.3452 Jiang, 1996, Calcium channel blockade and anti-free-radical actions of panaxatriol saponins in cultured myocardiocytes, Zhongguo Yao Li Xue Bao, 17, 138 Jover-Mengual, 2007, MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia, Endocrinology, 148, 1131, 10.1210/en.2006-1137 Kadowaki, 2005, Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation, Cell Death Differ., 12, 19, 10.1038/sj.cdd.4401528 Kalaitzidis, 2005, Transcription factor cross-talk: the estrogen receptor and NF-kappaB, Trends Endocrinol. Metab., 16, 46, 10.1016/j.tem.2005.01.004 Kassel, 2001, Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1, EMBO J., 20, 7108, 10.1093/emboj/20.24.7108 Kimura, 2007, Proapoptotic nitric oxide production in amyloid beta protein-treated cerebral microvascular endothelial cells, Microcirculation, 14, 89, 10.1080/10739680601131127 Kumar, 2009, Dexamethasone ameliorates renal ischemia-reperfusion injury, J. Am. Soc. Nephrol., 20, 2412, 10.1681/ASN.2008080868 Lee, 2008, Hormone effects on specific and global brain functions, J. Physiol. Sci., 58, 213, 10.2170/physiolsci.RV007008 Lee, 1997, Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor, Mol. Cell Endocrinol., 133, 135, 10.1016/S0303-7207(97)00160-3 Leung, 2007, Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity, Neuropharmacology, 52, 827, 10.1016/j.neuropharm.2006.10.001 Li, 2006, Role of ERK1/2 in the anti-apoptotic and cardioprotective effects of nitric oxide after myocardial ischemia and reperfusion, Apoptosis, 11, 923, 10.1007/s10495-006-6305-6 Lo, 2002, Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-kappaB in mouse macrophages, Carcinogenesis, 23, 983, 10.1093/carcin/23.6.983 Ma, 2010, Ginsenoside Rg1 promotes peripheral nerve regeneration in rat model of nerve crush injury, Neurosci. Lett., 478, 66, 10.1016/j.neulet.2010.04.064 Marchetti, 2005, Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia-neuron interactions, Brain Res. Brain Res. Rev., 48, 302, 10.1016/j.brainresrev.2004.12.030 Marcus, 2003, Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB, Glia, 41, 152, 10.1002/glia.10168 Melcangi, 2009, Neuroactive steroids: an update of their roles in central and peripheral nervous system, Psychoneuroendocrinology, 34, S1, 10.1016/j.psyneuen.2009.11.001 Meltser, 2009, Glucocorticoid receptor and mitogen-activated protein kinase activity after restraint stress and acoustic trauma, J. Neurotrauma, 26, 1835, 10.1089/neu.2008.0874 Mihm, 2001, Free 3-nitrotyrosine causes striatal neurodegeneration in vivo, J. Neurosci., 21, RC149, 10.1523/JNEUROSCI.21-11-j0003.2001 Numakawa, 2007, 17beta-estradiol protects cortical neurons against oxidative stress-induced cell death through reduction in the activity of mitogen-activated protein kinase and in the accumulation of intracellular calcium, Endocrinology, 148, 627, 10.1210/en.2006-1210 Reed, 2008, Proteomic identification of nitrated brain proteins in early Alzheimer’s disease inferior parietal lobule, J. Cell Mol. Med. Ribble, 2005, A simple technique for quantifying apoptosis in 96-well plates, BMC Biotechnol., 5, 12, 10.1186/1472-6750-5-12 Sawe, 2008, Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke, J. Neurosci. Res., 86, 1659, 10.1002/jnr.21604 Shiau, 1998, The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen, Cell, 95, 927, 10.1016/S0092-8674(00)81717-1 Sweatt, 2004, Mitogen-activated protein kinases in synaptic plasticity and memory, Curr. Opin. Neurobiol., 14, 311, 10.1016/j.conb.2004.04.001 Tanenbaum, 1998, Crystallographic comparison of the estrogen and progesterone receptor’s ligand binding domains, Proc. Natl. Acad. Sci. U.S.A., 95, 5998, 10.1073/pnas.95.11.5998 Tugcu, 2006, Selective nuclear factor kappa-B inhibitors, pyrolidium dithiocarbamate and sulfasalazine, prevent the nephrotoxicity induced by gentamicin, BJU Int., 98, 680, 10.1111/j.1464-410X.2006.06321.x Venkatachalam, 2003, LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites, J. Mol. Graph. Model., 21, 289, 10.1016/S1093-3263(02)00164-X Wang, 2007, Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway, Neuroscience, 145, 911, 10.1016/j.neuroscience.2006.12.059 Wenzel, 2001, Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor, Invest. Ophthalmol. Vis. Sci., 42, 1653 Wollen, 2010, Alzheimer’s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners, Altern. Med. Rev., 15, 223 Wu, 2010, Natural compounds from traditional medicinal herbs in the treatment of cerebral ischemia/reperfusion injury, Acta Pharmacol. Sin., 31, 1523, 10.1038/aps.2010.186 Xu, 2010, Rg1 protects iron-induced neurotoxicity through antioxidant and iron regulatory proteins in 6-OHDA-treated MES23.5 cells, J. Cell Biochem., 10.1002/jcb.22885 Yamakura, 1998, Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine, J. Biol. Chem., 273, 14085, 10.1074/jbc.273.23.14085 Yamamoto, 2001, Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer, J. Clin. Invest., 107, 135, 10.1172/JCI11914 Zigmond, 2006, Triggering endogenous neuroprotective mechanisms in Parkinson’s disease: studies with a cellular model, J. Neural. Transm. Suppl., 439, 10.1007/978-3-211-45295-0_66